CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.
Current Team (11)Update
Funding Rounds (7) - $229MUpdate
Board Members and Advisors (5)Update
2500 Faber Place
Palo Alto, CA 94303